Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML

By Litzow Mr   Dietz Ab   Bulur Pa   Butler Gw   Gastineau Da   Hoering A   Fink Sr   Letendre L   Padley Dj   Paternoster Sf   Tefferi A   Vuk-Pavlović S  

Cytotherapy, Vol. 8, Iss. 3, 2006-05 ,pp. : 290-298

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Clinical-grade myeloma Ag pre-loaded DC vaccines retain potency after cryopreservation

By Szmania S   Yi Q   Cottler-Fox M   Rosen NA   Freeman J   Kordsmeier BJ   Moreno A   Shi J   Barlogie B   Tricot G   van Rhee F  

Cytotherapy, Vol. 7, Iss. 4, 2005-09 ,pp. : 374-384

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

By Trepiakas Redas   Berntsen Annika   Hadrup Sine Reker   Bjørn Jon   Geertsen Poul F.   Straten Per Thor   Andersen Mads H.   Pedersen Anders E.   Soleimani Amir   Lorentzen Torben   Johansen Julia S.   Svane Inge Marie  

Cytotherapy, Vol. 12, Iss. 6, 2010-10 ,pp. : 721-734

Ashgate Publishing Ltd

Access to resources Recommend Favorite

mRNA transfection of DC in the immature or mature state: comparable in vitro priming of Th and cytotoxic T lymphocytes against DC electroporated with tumor cell line-derived mRNA

By Jarnjak-Jankovic S.   Saebøe-Larssen S.   Kvalheim G.   Gaudernack G.  

Cytotherapy, Vol. 9, Iss. 6, 2007-01 ,pp. : 587-592

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma

By Zhang Hong-Mei   Zhang Li-Wang   Liu Wen-Chao   Cheng Jie   Si Xiao-Ming   Ren Jun  

Cytotherapy, Vol. 8, Iss. 6, 2006-12 ,pp. : 580-588

Ashgate Publishing Ltd

Access to resources Recommend Favorite